Register for our free email digests:
Latest From Zimmer Biomet Holdings Inc.
US FDA Device-approval volumes were strong during the first half of 2017 for all review pathways. Medtronic and Siemens have so far captured the most 510(k) clearances, with Cook close behind. That and more from Medtech Insight's Approvals Tracker.
The case had gone to the US Supreme Court due to a dispute over the standards for enhanced damages. Zimmer, which was ordered to pay almost $250m in costs and penalties, expects to appeal the verdict.
The latest updates to the US Open Payments database show spending by device and diagnostics firms on physician royalties, consulting fees, education, research and more was a bit less in 2016 compared to 2015, but still substantial. Top "general payment" spending came from Medtronic, Zimmer Biomet, Johnson & Johnson, Stryker, Smith & Nephew and Intuitive Surgical; while top "research payments" were reported by Edwards Lifesciences, Boston Scientific, and Abbott Laboratories, according to the CMS database.
David Dvorak has stepped down as president and CEO, and from the company's board, and CFO Daniel P. Florin will take over as interim CEO, the orthopedics giant announced July 11. The company also announced preliminary second-quarter sales and earnings that, while within the previously projected range, included disappointments for several product lines.
- OTC, Consumer
- Therapeutic Areas
- Infectious & Viral Diseases
- ONI BioPharma Inc.
- North America
- Parent & Subsidiaries
- Oragenics Inc.
- Senior Management
Alan Joslyn, PhD, Pres. & CEO
Michael Sullivan, CFO
Martin Handfield, PhD, VP, Research
- Contact Info
Phone: (813) 286-7900
4902 Eisenhower Blvd., Ste. 125
Tampa, FL 33634
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.